AUTONOMOUS HEALTHCARE INC. — Department of Defense STTR Phase I: DHP17B-003
AUTONOMOUS HEALTHCARE INC. — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $149,991. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code DHP17B-003 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $149,991
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- STTR · Phase I
- Topic
- DHP17B-003
- Solicitation
- 17.B
- NAICS
- —
- Place of performance
- NJ
- Period
- 2018-04-09 → 2019-01-08
Description
Drug dosingcan bemademore precise by using pharmacokineticand pharmacodynamicmodeling. Pharmacokinetics is thestudy of the concentration of drugs in tissueasafunction of timeand doseschedule,whereas pharmacodynamics is thestudy of therelationship between drugconcentration and drugeffect. By relating doseto resultant drugconcentration (pharmacokinetics)and concentration to effect (pharmacodynamics),amodel for drug dosingcan begenerated.We proposeto develop acomputational frameworkfor system identification of pharmacokineticmodels,where we will usecompartmental dynamical systemsasageneral frameworkto model pharmacokinetics. A constrained optimization problem is formulated to find optimal parameters of thecompartmental model. A GPU-based numerical solver will be used to solvetheconstrained optimization problem.